Literature DB >> 19726542

AT1 receptor-mediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway.

Xiao C Li1, Ulrich Hopfer, Jia L Zhuo.   

Abstract

Angiotensin II (ANG II) is taken up by proximal tubule (PT) cells via AT1 (AT1a) receptor-mediated endocytosis, but the underlying cellular mechanisms remain poorly understood. The present study tested the hypothesis that the microtubule- rather than the clathrin-dependent endocytic pathway regulates AT1-mediated uptake of ANG II and ANG II-induced sodium and hydrogen exchanger-3 (NHE-3) expression in PT cells. The expression of AT1 receptors, clathrin light (LC) and heavy chain (HC) proteins, and type 1 microtubule-associated proteins (MAPs; MAP-1A and MAP-1B) in PT cells were knocked down by their respective small interfering (si) RNAs before AT1-mediated FITC-ANG II uptake and ANG II-induced NHE-3 expression were studied. AT1 siRNAs inhibited AT1 expression and blocked ANG II-induced NHE-3 expression in PT cells, as expected (P < 0.01). Clathrin LC or HC siRNAs knocked down their respective proteins by approximately 90% with a peak response at 24 h, and blocked the clathrin-dependent uptake of Alexa Fluor 594-transferrin (P < 0.01). However, neither LC nor HC siRNAs inhibited AT1-mediated uptake of FITC-ANG II or affected ANG II-induced NHE-3 expression. MAP-1A or MAP-1B siRNAs markedly knocked down MAP-1A or MAP-1B proteins in a time-dependent manner with peak inhibitions at 48 h (>76.8%, P < 0.01). MAP protein knockdown resulted in approximately 52% decreases in AT1-mediated FITC-ANG II uptake and approximately 66% decreases in ANG II-induced NHE-3 expression (P < 0.01). These effects were associated with threefold decreases in ANG II-induced MAP kinases ERK 1/2 activation (P < 0.01), but not with altered AT1 expression or clathrin-dependent transferrin uptake. Both losartan and AT1a receptor deletion in mouse PT cells completely abolished the effects of MAP-1A knockdown on ANG II-induced NHE-3 expression and activation of MAP kinases ERK1/2. Our findings suggest that the alternative microtubule-dependent endocytic pathway, rather than the canonical clathrin-dependent pathway, plays an important role in AT1 (AT1a)-mediated uptake of extracellular ANG II and ANG II-induced NHE-3 expression in PT cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726542      PMCID: PMC2781332          DOI: 10.1152/ajprenal.90734.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  52 in total

Review 1.  Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton.

Authors:  G Apodaca
Journal:  Traffic       Date:  2001-03       Impact factor: 6.215

Review 2.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

3.  Subcellular localization of angiotensin II in kidney and adrenal.

Authors:  J P van Kats; J R van Meegen; P D Verdouw; D J Duncker; M A Schalekamp; A H Danser
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

4.  Rapid activation of Na+/H+-exchange in MDCK cells by aldosterone involves MAP-kinase ERK1/2.

Authors:  M Gekle; R Freudinger; S Mildenberger; K Schenk; I Marschitz; H Schramek
Journal:  Pflugers Arch       Date:  2001-03       Impact factor: 3.657

5.  Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor.

Authors:  Jia L Zhuo; John D Imig; Timothy G Hammond; Sheyla Orengo; Edmund Benes; L Gabriel Navar
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

6.  Inhibition of AT1 receptor internalization by concanavalin A blocks angiotensin II-induced ERK activation in vascular smooth muscle cells. Involvement of epidermal growth factor receptor proteolysis but not AT1 receptor internalization.

Authors:  H Tang; T Nishishita; T Fitzgerald; E J Landon; T Inagami
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

7.  Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes.

Authors:  Bukhtiar H Shah; J Alberto Olivares-Reyes; Akin Yesilkaya; Kevin J Catt
Journal:  Mol Endocrinol       Date:  2002-03

8.  Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia.

Authors:  R Kozyraki; J Fyfe; P J Verroust; C Jacobsen; A Dautry-Varsat; J Gburek; T E Willnow; E I Christensen; S K Moestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla.

Authors:  Xiao C Li; Yuan Shao; Jia L Zhuo
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

10.  Role of c-SRC and ERK in acid-induced activation of NHE3.

Authors:  Hirohiko Tsuganezawa; Soichiro Sato; Yasuyoshi Yamaji; Patricia A Preisig; Orson W Moe; Robert J Alpern
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  42 in total

Review 1.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Podocyte Injury Augments Intrarenal Angiotensin II Generation and Sodium Retention in a Megalin-Dependent Manner.

Authors:  Masahiro Koizumi; Kohei Ueda; Fumio Niimura; Akira Nishiyama; Motoko Yanagita; Akihiko Saito; Ira Pastan; Toshiro Fujita; Masafumi Fukagawa; Taiji Matsusaka
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

Review 4.  Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update.

Authors:  Tianxin Yang; Chuanming Xu
Journal:  J Am Soc Nephrol       Date:  2017-03-02       Impact factor: 10.121

5.  Luminal ANG II is internalized as a complex with AT1R/AT2R heterodimers to target endoplasmic reticulum in LLC-PK1 cells.

Authors:  Fernanda M Ferrão; Luiza H D Cardoso; Heather A Drummond; Xiao C Li; Jia L Zhuo; Dayene S Gomes; Lucienne S Lara; Adalberto Vieyra; Jennifer Lowe
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-03

6.  Actin cytoskeleton-dependent Rab GTPase-regulated angiotensin type I receptor lysosomal degradation studied by fluorescence lifetime imaging microscopy.

Authors:  Hewang Li; Peiying Yu; Yuansheng Sun; Robin A Felder; Ammasi Periasamy; Pedro A Jose
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

7.  Novel signaling mechanisms of intracellular angiotensin II-induced NHE3 expression and activation in mouse proximal tubule cells.

Authors:  X C Li; U Hopfer; J L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

8.  Gender difference in kidney electrolyte transport. I. Role of AT1a receptor in thiazide-sensitive Na+-Cl- cotransporter activity and expression in male and female mice.

Authors:  Jing Li; Ryo Hatano; Shuhua Xu; Laxiang Wan; Lei Yang; Alan M Weinstein; Lawrence Palmer; Tong Wang
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31

9.  Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

10.  Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.

Authors:  Hiromichi Wakui; Kouichi Tamura; Shin-Ichiro Masuda; Yuko Tsurumi-Ikeya; Megumi Fujita; Akinobu Maeda; Masato Ohsawa; Kengo Azushima; Kazushi Uneda; Miyuki Matsuda; Kenichiro Kitamura; Shinichi Uchida; Yoshiyuki Toya; Hiroyuki Kobori; Kiyotaka Nagahama; Akio Yamashita; Satoshi Umemura
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.